APP Processing and Synaptic Function

Neuron

Volumn 37, Issue 6, 2003, Pages 925-937

  Kamenetz, Flavio ^a,b   Tomita, Taisuke ^c   Hsieh, Helen ^a,b   Seabrook, Guy ^d   Borchelt, David ^e   Iwatsubo, Takeshi ^c   Sisodia, Sangram ^f   Malinow, Roberto ^a,b  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d MERCK RESEARCH LABORATORIES   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; CELL ACTIVITY; COGNITIVE DEFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SYNAPTIC TRANSMISSION;

EID: 0344672942     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00124-7     Document Type: Article

References (66)

1. Bacskai B.J., Kajdasz S.T., Christie R.H., Carter C., Games D., Seubert P., Schenk D., Hyman B.T. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 7:2001;369-372.
2. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D.et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
3. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
4. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D.R., Price D.L., Wong P.C. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4:2001;233-234.
5. Cao X., Sudhof T.C. A transcriptively active complex of app with fe65 and histone acetyltransferase tip60. Science. 293:2001;115-120.
6. Carroll R.C., Beattie E.C., von Zastrow M., Malenka R.C. Role of AMPA receptor endocytosis in synaptic plasticity. Nat. Rev. Neurosci. 2:2001;315-324.
7. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T.et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
8. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 360:1992;672-674.
9. Citron M., Teplow D.B., Selkoe D.J. Generation of amyloid beta protein from its precursor is sequence specific. Neuron. 14:1995;661-670.
10. Cotman C.W., Pike C.J., Copani A. Beta-amyloid neurotoxicity. a discussion of in vitro findings Neurobiol. Aging. 13:1992;587-590.
11. Cullen W.K., Suh Y.H., Anwyl R., Rowan M.J. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport. 8:1997;3213-3217.
12. Davis G.W., DiAntonio A., Petersen S.A., Goodman C.S. Postsynaptic PKA controls quantal size and reveals a retrograde signal that regulates presynaptic transmitter release in Drosophila. Neuron. 20:1998;305-315.
13. De Strooper B., Simons M., Multhaup G., Van Leuven F., Beyreuther K., Dotti C.G. Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 14:1995;4932-4938.
14. Fastbom J., Forsell Y., Winblad B. Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis. Assoc. Disord. 12:1998;14-17.
15. Fezoui Y., Hartley D.M., Harper J.D., Khurana R., Walsh D.M., Condron M.M., Selkoe D.J., Lansbury P.T. Jr., Fink A.L., Teplow D.B. An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments. Amyloid. 7:2000;166-178.
16. Fitzjohn S.M., Morton R.A., Kuenzi F., Rosahl T.W., Shearman M., Lewis H., Smith D., Reynolds D.S., Davies C.H., Collingridge G.L.et al. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that over-express the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci. 21:2001;4691-4698.
17. Freir D.B., Holscher C., Herron C.E. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85:2001;708-713.
18. Furukawa K., Barger S.W., Blalock E.M., Mattson M.P. Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature. 379:1996;74-78.
19. Greenfield J.P., Tsai J., Gouras G.K., Hai B., Thinakaran G., Checler F., Sisodia S.S., Greengard P., Xu H. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl. Acad. Sci. USA. 96:1999;742-747.
20. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., Selkoe D.J. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:1999;8876-8884.
21. Hayashi Y., Shi S.H., Esteban J.A., Piccini A., Poncer J.C., Malinow R. Driving AMPA receptors into synapses by LTP and CaMKII. requirement for GluR1 and PDZ domain interaction Science. 287:2000;2262-2267.
22. Howland, D.S., Trusko, S.P., Savage, M.J., Reaume, A.G., Lang, D.M., Hirsch, J.D., Maeda, N., Siman, R., Greenberg, B.D., Scott, R.W., et al. (1998). Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J. Biol. Chem. 273, 16576-15682.
23. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
24. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
25. Iwata H., Tomita T., Maruyama K., Iwatsubo T. Subcellular compartment and molecular subdomain of beta-amyloid precursor protein relevant to the Abeta 42-promoting effects of Alzheimer mutant presenilin 2. J. Biol.Chem. 276:2001;21678-21685.
26. Jarrett J.T., Berger E.P., Lansbury P.T. Jr. The C-terminus of the beta protein is critical in amyloidogenesis. Ann. N Y Acad. Sci. 695:1993;144-148.
27. Johnstone E.M., Chaney M.O., Norris F.H., Pascual R., Little S.P. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res. Mol. Brain Res. 10:1991;299-305.
28. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature. 414:2001;643-648.
29. Kim J.H., Anwyl R., Suh Y.H., Djamgoz M.B., Rowan M.J. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci. 21:2001;1327-1333.
30. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L.et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:1998;6448-6453.
31. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840:1999;23-35.
32. Li Y.M., Xu M., Lai M.T., Huang Q., Castro J.L., DiMuzio-Mower J., Harrison T., Lellis C., Nadin A., Neduvelil J.G.et al. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature. 405:2000;689-694.
33. Luo Y., Bolon B., Kahn S., Bennett B.D., Babu-Khan S., Denis P., Fan W., Kha H., Zhang J., Gong Y.et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 4:2001;231-232.
34. Malinow R., Hayashi Y., Maletic-Savatic M., Zaman S., Poncer J.-C., Shi S.-H., Esteban J. Introduction of Green Fluorescent Protein into Hippocampal Neurons through Viral Infection. 1999;Cold Spring Harbor Press, Cold Spring Harbor, New York.
35. Malinow R., Mainen Z.F., Hayashi Y. LTP mechanisms. from silence to four-lane traffic Curr. Opin. Neurobiol. 10:2000;352-357.
36. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D.et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
37. Nitsch R.M., Farber S.A., Growdon J.H., Wurtman R.J. Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. USA. 90:1993;5191-5193.
38. Perez R.G., Soriano S., Hayes J.D., Ostaszewski B., Xia W., Selkoe D.J., Chen X., Stokin G.B., Koo E.H. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J. Biol. Chem. 274:1999;18851-18856.
39. Price D.L., Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21:1998;479-505.
40. Reisberg, B., Windscheif, U., Ferris, S.H., Hingorani, V.N., Stoeffler, A., and Moebius, H. (2000). Memantine in Moderately Severe to Severe Alzheimer's Disease: Results of a Placebo Controlled 6-Month Trial. In World Alzheimer's Congress (Washington D.C.).
41. Sabo S.L., Ikin A.F., Buxbaum J.D., Greengard P. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153:2001;1403-1414.
42. Sastre M., Turner R.S., Levy E. X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion. J. Biol. Chem. 273:1998;22351-22357.
43. Scanziani M., Malenka R.C., Nicoll R.A. Role of intercellular interactions in heterosynaptic long-term depression. Nature. 380:1996;446-450.
44. Schlesinger S., Dubensky T.W. Alphavirus vectors for gene expression and vaccines. Curr. Opin. Biotechnol. 10:1999;434-439.
45. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis. Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein Ann. N Y Acad. Sci. 924:2000;17-25.
46. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science. 298:2002;789-791.
47. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C.et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 359:1992;325-327.
48. Shi S.H., Hayashi Y., Petralia R.S., Zaman S.H., Wenthold R.J., Svoboda K., Malinow R. Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science. 284:1999;1811-1816.
49. Sisodia S.S., Koo E.H., Hoffman P.N., Perry G., Price D.L. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J. Neurosci. 13:1993;3136-3142.
50. Steinbach J.P., Muller U., Leist M., Li Z.W., Nicotera P., Aguzzi A. Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ. 5:1998;858-866.
51. Stephan A., Laroche S., Davis S. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21:2001;5703-5714.
52. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37:1991;173-182.
53. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos L. Jr., Eckman C., Golde T.E., Younkin S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1994;1336-1340.
54. Tomita T., Maruyama K., Saido T.C., Kume H., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grunberg J., Haass C.et al. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA. 94:1997;2025-2030.
55. Turrigiano G.G., Leslie K.R., Desai N.S., Rutherford L.C., Nelson S.B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature. 391:1998;892-896.
56. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., Teplow D.B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:1999;25945-25952.
57. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
58. Wasco W., Gurubhagavatula S., Paradis M.D., Romano D.M., Sisodia S.S., Hyman B.T., Neve R.L., Tanzi R.E. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. Nat. Genet. 5:1993;95-100.
59. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., Carlson G.A., Younkin S.G., Ashe K.H. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22:2002;1858-1867.
60. Winblad B., Poritis N. Memantine in severe dementia. results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine) Int. J. Geriatr. Psychiatry. 14:1999;135-146.
61. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.
62. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein. reversal by tachykinin neuropeptides Science. 250:1990;279-282.
63. Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A., Song Y.Q., Rogaeva E., Chen F., Kawarai T.et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature. 407:2000;48-54.
64. Zheng H., Jiang M., Trumbauer M.E., Hopkins R., Sirinathsinghji D.J., Stevens K.A., Conner M.W., Slunt H.H., Sisodia S.S., Chen H.Y.et al. Mice deficient for the amyloid precursor protein gene. Ann. N Y Acad. Sci. 777:1996;421-426.
65. Zhu J.J., Esteban J.A., Hayashi Y., Malinow R. Postnatal synaptic potentiation. delivery of GluR4-containing AMPA receptors by spontaneous activity Nat. Neurosci. 3:2000;1098-1106.
66. Zoghbi H.Y., Gage F.H., Choi D.W. Neurobiology of disease. Curr. Opin. Neurobiol. 10:2000;655-660.